Endocrine oncologists specialize in the diagnosis and treatment of hormone-secreting tumors affecting the endocrine system, including thyroid carcinomas, adrenocortical neoplasms, and neuroendocrine tumors of the pancreas and pituitary. Their expertise combines oncology principles with intricate hormonal regulation, allowing them to assess not only tumor behavior but also endocrine disruptions caused by tumor activity or treatment.
Endocrine oncologists manage complex cases that often involve a multidisciplinary approach, working closely with nuclear medicine, endocrine surgeons, and pathologists to tailor personalized treatment plans. They evaluate the hormonal output of tumors, interpret tumor markers, and oversee therapies such as radioactive iodine, targeted agents, or peptide receptor radionuclide therapy (PRRT). Their role is particularly critical in balancing oncologic treatment with the preservation of endocrine function, mitigating complications like adrenal insufficiency or hypopituitarism. As the prevalence of hormone-related cancers rises, endocrine oncologists continue to refine therapeutic algorithms, ensuring patients benefit from both disease control and endocrine equilibrium.










Title : Changes in the global incidence of diabetes over a quarter century
F Buck Willis, Christian College of Medicine
Title : Vascular health with glucagon-like peptide-1 receptor agonists
Mahir Khalil Ibrahim Jallo, Thumbay University Hospital
Title : The prowess of Overripe Banana Sweetener (OBS) in enhancing nutritive values in food and ameliorating glycaemic responses in type 2 diabetes mellitus
Wan Rosli Wan Ishak, Universiti Sains Malaysia
Title : Wound care 2.0 creating a wound care culture TM
David Navazio, Gentell
Title : Association between diabetes technology use and prevalent macrovascular disease in adults with type 1 diabetes: A cross-sectional analysis
Divanshi Trivedi, London Northwest Hospital NHS Foundation Trust
Title : Beyond the prescription: Using GLP 1 science and lifestyle coaching to prevent prediabetes and support long term blood sugar control
Keith Hersey, Founder/CEO Destroying Diabetes
Title : Intensive versus standard blood pressure control in type 2 diabetes: Cardiovascular and microvascular outcomes
Muhammad Basil Raza, East Lancashire Hospitals NHS Trust
Title : Fetomaternal outcomes in gestational diabetes mellitus with and without polycystic ovary syndrome
Vinita Singh, AIIMS
Title : Effects of a structured education program on glycemic control in type 1 diabetes
Ana Paula Franco Pacheco, Estacio University of Brasília
Title : Cardiorespiratory fitness inflammatory and neurotrophic biomarkers and cognitive function in early versus longer duration type 2 diabetes mellitus
Arbind Kumar Choudhary, All India Institute of Medical Sciences